Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.02 -0.90 (-30.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Foghorn Therapeutics (FHTX) Return on Sales [ROS] (2020 - 2026)

Updated

Foghorn Therapeutics (FHTX) reported Return on Sales [ROS] of -54.78% for Q2 2026, up 224.39 percentage points from -279.17% a year earlier and up 605.55 percentage points from the prior quarter.

Analysis

Foghorn Therapeutics (FHTX) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Foghorn Therapeutics' Return on Sales [ROS] came in at -198.04%, up 182.00 percentage points year-over-year; for FY2025, it was -279.49%, up 174.81 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of +15657.95 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -454.31% in FY2024 (-138.38 pp), -315.93% in FY2023 (+293.27 pp), -609.20% in FY2022 (+7027.95 pp) and -7637.15% in FY2021 (+8300.29 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] in data going back to Q3 2020.
  • Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of +35.46 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q3 2022 (a gain of 63625.25 percentage points); the low point was Q3 2021 (a drop of 53722.17 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -660.33% (Q1 2026), -258.22% (Q4 2025) and -226.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 28.21%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 37.86%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 32.97%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 20.57%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -133.21%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 28.37%
10 Foghorn Therapeutics 171.45 Mn -154.51 Mn - -54.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -54.78%
Mar 31, 2026 -660.33%
Dec 31, 2025 -258.22%
Sep 30, 2025 -226.92%
Jun 30, 2025 -279.17%
Mar 31, 2025 -384.96%
Dec 31, 2024 -840.51%
Sep 30, 2024 -305.48%
Jun 30, 2024 -386.64%
Mar 31, 2024 -558.30%
Dec 31, 2023 -441.29%
Sep 30, 2023 -97.73%
Jun 30, 2023 -572.42%
Mar 31, 2023 -627.56%
Dec 31, 2022 -762.09%
Sep 30, 2022 -425.97%
Jun 30, 2022 -650.07%
Mar 31, 2022 -709.29%
Dec 31, 2021 -3,938.57%
Sep 30, 2021 -64,051.22%
API Access

Foghorn Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FHTX&period=max&api_key=YOUR_API_KEY